P460: Efficacy of ustekinumab in patients with anti-TNF refractory Crohn’s disease: data from a real-world study in Brazil
ECCO '19 Copenhagen
2019
P461: Endoscopic features for loss of response in patients with Crohn’s disease who were treated with infliximab by top-down strategy
ECCO '19 Copenhagen
2019
P463: Factors to determine prognosis of intestinal cancer associated with Crohn’s disease
ECCO '19 Copenhagen
2019
P464: Study of the usual aetiologies of methotrexate and azathioprine discontinuation in inflammatory bowel disease
ECCO '19 Copenhagen
2019
P465: UC trial designed more than 5 years ago in the light of the EMA guideline on the development of new medicinal products for the treatment of ulcerative colitis
ECCO '19 Copenhagen
2019
P466: Tofacitinib for the treatment of ulcerative colitis: Up to 5.4 years of safety data from global clinical trials
ECCO '19 Copenhagen
2019
P467: Circulating CD8 α4β7+ and CD8b7+ memory T cells as early biomarkers of clinical response to vedolizumab in ulcerative colitis
ECCO '19 Copenhagen
2019
P468: Long-term function after transanal vs. transabdominal ileal pouch-anal anastomosis for ulcerative colitis: a multi-centre cohort study
ECCO '19 Copenhagen
2019
P469: Effectiveness of dose optimisation by pre-genotyping NUDT 15 R139C on reducing thiopurine-induced leucopoenia in Chinese patients with Crohn’s disease: a randomised controlled trial
ECCO '19 Copenhagen
2019
P470: DUBLIN (Degree of Ulcerative colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitis
ECCO '19 Copenhagen
2019
P471: Association of vedolizumab levels with clinical and biochemical markers of inflammation during maintenance therapy in inflammatory bowel disease
ECCO '19 Copenhagen
2019
P472: Efficacy of intravenous ustekinumab re-induction in patients with Crohn’s disease with a loss of response
ECCO '19 Copenhagen
2019
P473: Cumulative histological inflammation predicts colorectal neoplasia in ulcerative colitis
ECCO '19 Copenhagen
2019
P474: Analysis of UC colectomy rates in pre- and post-biologic era in South-East Scotland
ECCO '19 Copenhagen
2019
P475: Rapid point-of-care anti-drug antibodies measurement correlates with standardised T tests and facilitate a proactive therapeutic drug monitoring approach in IBD patients on anti-TNF-α maintenance therapy
ECCO '19 Copenhagen
2019
P476: Combined therapy with adalimumab and mesenchymal stromal cells contributes to reduction in the degree of inflammation in ulcerative colitis
ECCO '19 Copenhagen
2019
P477: Clinical remission by legacy vs. FDA definitions: definition justification and results from UNIFI Study
ECCO '19 Copenhagen
2019